
Mainstream Bio
主流源生物
Mainstream Bio
Biotech/Healthcare
Mainstream Biosciences is an R&D-focused biotechnology company developing next-generation peptide therapeutics. Using its advanced, differentiated peptide-drug conjugate platform and multifunctional peptide screening and optimization platform, the company has developed a pipeline of peptide drug…
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.